Furthermore, the number of EPCs in PAH patients with BMPR2 mutations are increased and when grown in vitro demonstrate a hyperproliferative phenotype and an inability to form vessel networks (83). The gene discussed is BMPR2; the disease is pulmonary arterial hypertension.